eF-site ID 6vww-A
PDB Code 6vww
Chain A

click to enlarge
Title Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2.
Classification VIRAL PROTEIN
Compound Uridylate-specific endoribonuclease
Source (R1AB_SARS2)
Sequence A:  NMSLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGV
DVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVD
IAANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAP
LTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPK
QASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSR
NLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYG
DFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNY
FITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVV
KVTIDYTEISFMLWCKDGHVETFYPKLQ
Description


Functional site

1) chain A
residue 43
type
sequence L
description binding site for residue GOL A 401
source : AC1

2) chain A
residue 44
type
sequence F
description binding site for residue GOL A 401
source : AC1

3) chain A
residue 45
type
sequence E
description binding site for residue GOL A 401
source : AC1

4) chain A
residue 267
type
sequence E
description binding site for residue GOL A 401
source : AC1

5) chain A
residue 126
type
sequence G
description binding site for residue GOL A 402
source : AC2

6) chain A
residue 127
type
sequence R
description binding site for residue GOL A 402
source : AC2

7) chain A
residue 145
type
sequence T
description binding site for residue GOL A 402
source : AC2

8) chain A
residue 146
type
sequence E
description binding site for residue GOL A 402
source : AC2

9) chain A
residue 147
type
sequence G
description binding site for residue GOL A 402
source : AC2

10) chain A
residue 262
type
sequence S
description binding site for residue MG A 403
source : AC3

11) chain A
residue 263
type
sequence P
description binding site for residue MG A 403
source : AC3

12) chain A
residue 283
type
sequence D
description binding site for residue MG A 403
source : AC3

13) chain A
residue 284
type
sequence A
description binding site for residue MG A 403
source : AC3

14) chain A
residue 285
type
sequence Q
description binding site for residue MG A 403
source : AC3

15) chain A
residue 77
type
sequence G
description binding site for residue GOL A 404
source : AC4

16) chain A
residue 79
type
sequence D
description binding site for residue GOL A 404
source : AC4

17) chain A
residue 119
type
sequence P
description binding site for residue GOL A 404
source : AC4

18) chain A
residue 69
type
sequence E
description binding site for residue GOL A 405
source : AC5

19) chain A
residue 90
type
sequence K
description binding site for residue GOL A 405
source : AC5

20) chain A
residue 167
type
sequence T
description binding site for residue GOL A 405
source : AC5

21) chain A
residue 198
type
sequence S
description binding site for residue GOL A 405
source : AC5

22) chain A
residue 200
type
sequence N
description binding site for residue GOL A 405
source : AC5

23) chain A
residue 200
type
sequence N
description binding site for residue ACY A 406
source : AC6

24) chain A
residue 201
type
sequence L
description binding site for residue ACY A 406
source : AC6

25) chain A
residue 279
type
sequence Y
description binding site for residue ACY A 406
source : AC6

26) chain A
residue 322
type
sequence T
description binding site for residue CL B 404
source : AD1

27) chain A
residue 294
type SITE
sequence S
description Uracil recognition site => ECO:0000269|PubMed:33504779, ECO:0000269|PubMed:33564093
source Swiss-Prot : SWS_FT_FI7

28) chain A
residue 347
type SITE
sequence Q
description Cleavage; by 3CL-PRO => ECO:0000250|UniProtKB:P0C6V3
source Swiss-Prot : SWS_FT_FI8

29) chain A
residue 235
type ACT_SITE
sequence H
description Proton donor; for uridylate-specific endoribonuclease nsp15 activity => ECO:0000269|PubMed:33504779, ECO:0000269|PubMed:33564093
source Swiss-Prot : SWS_FT_FI1

30) chain A
residue 250
type ACT_SITE
sequence H
description Proton acceptor; for uridylate-specific endoribonuclease nsp15 activity => ECO:0000269|PubMed:33504779, ECO:0000269|PubMed:33564093
source Swiss-Prot : SWS_FT_FI2

31) chain A
residue 290
type ACT_SITE
sequence K
description For uridylate-specific endoribonuclease nsp15 activity => ECO:0000269|PubMed:33504779
source Swiss-Prot : SWS_FT_FI3

32) chain A
residue 290
type BINDING
sequence K
description BINDING => ECO:0000269|PubMed:33504779, ECO:0000269|PubMed:33564093
source Swiss-Prot : SWS_FT_FI4

33) chain A
residue 341
type BINDING
sequence T
description BINDING => ECO:0000269|PubMed:33564093
source Swiss-Prot : SWS_FT_FI5

34) chain A
residue 290
type SITE
sequence K
description Transition state stabilizer => ECO:0000269|PubMed:33504779, ECO:0000269|PubMed:33564093
source Swiss-Prot : SWS_FT_FI6


Display surface

Download
Links